MedTrace Logo

Patient Decision Aid Tool for HPV Vaccination Among Adults Ages 27-45 Years Old

NCT06435338 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 632

Last updated 2024-05-30

No results posted yet for this study

Summary

The goal of this study is to learn if a patient decision tool for HPV vaccination works for decision-making among adults ages 27-45. Researchers will compare a web-based patient decision tool to an information sheet to see if the tool works for decision-making. Participants will take a baseline survey, view the intervention or control condition, and then take a follow-up survey.

Conditions

  • Decision Aid
  • Hpv

Interventions

BEHAVIORAL

Patient decision aid

The patient decision aid for HPV vaccination among mid-adults, named HPV Decide. It is delivered online on a website.

BEHAVIORAL

Control

Vaccine information sheet on HPV vaccination. Attention control condition.

Sponsors & Collaborators

  • University of North Texas Health Science Center

    collaborator OTHER

  • University of South Florida

    collaborator OTHER

  • Temple University

    collaborator OTHER

  • Indiana University School of Medicine

    collaborator OTHER

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
27 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-13
Primary Completion
2024-01-18
Completion
2024-01-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06435338 on ClinicalTrials.gov